Evaluation of the effectiveness of Matricaria recutita Linn. in the prevention and control of radiation-induced oral mucositis
Keywords:
Head and neck neoplasms, radiotherapy, mucositis, phytotherapy, chamomile,Abstract
Objective: To investigate the effectiveness of Matricaria recutita Linn. (chamomile) in the prevention and control of radiation-induced oral mucositis. Methods: The sample consisted of 22 patients who were divided into three groups: group I (experimental) (n=7), patients were treated with 3% chamomile gel throughout the radiotherapy course; group II (positive control) (n=7), the treatment was carried out using 1% chlorhexidine gluconate gel only at the onset of mucositis until regression of symptoms; and group III (experimental) (n=8), patients with mucositis were treated with 3% chamomile gel following the same protocol described for group II. Results: The results showed there were no statistically significant differences between the three groups (P>0.05). However, descriptive data indicated that group II was found to show the fastest clinical improvement in oral treatment, whereas group III took the longest period to show clinical improvement of mucositis. Conclusion: Chamomile had no prophylactic effect on the onset of oral mucositis, but it was proven to be effective in decreasing the severity of this condition during treatment in most patients.References
Scully C, Porter S. Oral cancer. West J Med 2001;174(5):348-51.
Bonan PRF, Pires FR, Lopes MA, Hipólito JO. Evaluation of salivary flow in patients during head and neck radiotherapy. Pesqui Odontol Bras 2003;17(2):156-60.
Tolentino ES, Centurion BS, Ferreira LHC, Souza AP, Damante JH, Rubira-Bullen IRF. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 2011;19(5):448-54.
Andrews N, Griffiths C. Dental complications of head and neck
radiotherapy. J Austr Dent 2001;46:88-4.
Köstler W J, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001;51:290-15.
Roopashri G, Jayanthi K, Guruprasad R. Efficacy of benzydamine
hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail. Contemp Clin Dent 2011;2(1):8-12.
Dörr W, Hamilton CS, Boyd T, Reed B, Denham JW. Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys 2001;52(4):911-7.
Sutherland, SE, Browman, GP. Prophylaxis of oral mucositis in irradiated head and neck cancer patients: a proposed classification scheme of interventions and meta – analysis of randomized controlled trials. Int J Radiat Oncol Biol Phys 2001; 49(4):917-30.
Volpato LER, Silva TC, Oliveira TM, Sakai VT, Machado MAAM.
Radiation therapy and chemotherapy-induced oral mucositis. Rev Bras Otorrinolaringol 2007; 73(4):562-8.
Mckay DL, Blumberg JB. A review of the bioactivity and potential health benefits of Chamomile Tea (Matricaria recutita L.). Phytother Res 2006; (20):519-30.
World Medical Association Declaration of Helsinki. Adopted by the 18th WMA General Assembly, Helsinki, Finland (1964)[online] [Acessed: Aug. 2012].
Karnofsky DA, Burchenal JH, Armistead GC, Craver LF. Trienthylinemelamine in the treatment of neoplastic disease. Arch Intern Med 1951; 87:477-16.
Lockhart PT, Clark, J. Pretherapy dental status of pacients with malignant conditions of the head and neck.Oral Surg Oral Med Oral Pathol 1994;77(3):236-41.
Miller A B,Hoogstrate MB, Staquet M, Winkler A. Reporting results of cancer. Cancer 1981;47:207-14.
Lima AG, Antequera R, Peres MPSM, Snitcosky IML,Federico MHH, Villar RC. Efficacy of Low-Level Laser Therapy and Aluminum Hydroxide in Patients with Chemotherapy and Radiotherapy-Induced Oral Mucositis. Braz Dent J 2010;21(3):186-92.
Weijers M, Leemans CR, Aartman IH, Karagozoglu KH, Isaäc van-der-Waal I. Oral cancer trends in a single head-and-neck cancer center in the Netherlands; decline in T-stage at the time of admission. Med Oral Patol Oral Cir Bucal 2011;16(7):914-8.
Suresh AVS, Varma PP, Sinha S, Deepika S, Raman R, Srinivasan M et al. Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent Chemoradiotherapy. J Cancer Res Ther 2010;6(4):448-51.
Durazzo MD, Araujo CEN, Brandão Neto JS, Potenza AS, Costa P, Takeda F et al. Clinical and epidemiological features of oral cancer in a medical school teaching hospital from 1994 to 2002: increasing incidence in women, predominance of advanced local disease, and low incidence of neck metastases. Clinics 2005;60(4):293-8.
Epstein JB, Klasser GD. Emerging approaches for prophylaxis in cancer management of oropharyngeal mucositis in cancer therapy. Expert Opin Emerg Drugs 2006;11(2):353-73.
Handschel J, Sunderköter C, Prott FJ, Meyer U, Kruse-Lösler B, Joos U. Increase of RM 3/1 – positive macrophages in radiation induced oral mucositis. J Pathol 2001;193(2):242-7.
Sonis ST. A biological approach to mucositis. J Support Oncol 2004; 2(1):21-6.
Lanzós I, Herrera D, Santos S, O’Connor A, Peña C, Lanzós E et al.
Mucositis in irradiated câncer patients: Effects of an antiseptic mouthrinse. Med Oral Patol Oral Cir Bucal 2010;15(5):732-78.
Soares AF, Aquino ARL, Carvalho CHP, Nonaka CFW, Almeida D, Pereira Pinto L. Frequency of Oral Mucositis and Microbiological Analysis in Children with Acute Lymphoblastic Leukemia Treated with 0.12% Chlorhexidine Gluconate. Braz Dent J 2011;22(4):312-6.
Mazokopakis EE, Vrentzos GE, Papadakis JA, Babalis DE, Ganotakis ES. Wild chamomile (Matricaria recutita L.) mouthwashes in methotrexateinduced oral mucosits. Phytomedicine 2005;12(1):25-7.
Pavesi VCS. et al. Healing action of topical chamomile on 5-fluouracil induced oral mucositis in hamster. Support Care Cancer 2011;19: 639-46.
Oehler C, Bensdorf K, Gust R, Imming P. Chamavioline – Antiedematous, but not a constituent of Matricaria recutita L. Phytochem Lett 2009;2(4): 171-5.
Downloads
Published
Issue
Section
License
COPYRIGHT
The submission of originals to Odonto Ciência implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Odonto Ciência as the site of original publication.
CREATIVE COMMONS LICENSE
As this journal is open access, the articles are allowed free use in scientific and educational applications, with citation of the source.
According to the type of Creative Commons License (CC-BY 4.0) adopted by Odonto Ciência, the user must respect the requirements below.
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
However, only under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests Odonto Ciência endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
For more details on the Creative Commons license, please follow the link in the footer of this website.
